# Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas

> **NCT00766753** · PHASE1,PHASE2 · COMPLETED · sponsor: **Frank Lieberman** · enrollment: 22 (actual)

## Conditions studied

- Malignant Glioma

## Interventions

- **BIOLOGICAL:** Dendritic vaccine pulsed with multiple peptides
- **BIOLOGICAL:** The first booster vaccine phase:
- **BIOLOGICAL:** The second booster vaccine phase:

## Key facts

- **NCT ID:** NCT00766753
- **Lead sponsor:** Frank Lieberman
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2009-09
- **Final completion:** 2016-06
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2018-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00766753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00766753, "Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT00766753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*